Table 1. Joint effect and interaction of low methylation and elderly age on the prognosis of early-stage lung adenocarcinoma (LUAD).
Effect type a | Elderly b | Low methylation | Number | Death | Crude mortality | HR (95% CI) a | Pa |
No | No | 75 | 17 | 22.67% | Ref. | ||
Main effect 1 | No | Yes | 70 | 33 | 47.14% | 2.8398 (1.5876,5.0798) | 4.35×10-4 |
Main effect 2 | Yes | No | 217 | 98 | 45.16% | 3.1804 (1.8542,5.4553) | 2.64×10-5 |
Joint effect | Yes | Yes | 222 | 70 | 31.53% | 1.8590 (1.0840,3.1890) | 0.0242 |
Interaction c | 0.2058 (0.1070,0.3961) | 2.20×10-6 |
a Patients categorized into two groups (low vs high) by medium of cg14326354PRODH methylation level. Classification criteria of age were based on boundary of 95% confidence interval (CI) standard (young: <57 years; elderly >65 years).
b Main effects of low methylation and elderly age and their joint effect and interaction were derived from Cox proportional hazards model adjusted for covariates.
c Interaction = Joint effect ÷ (Main effect 1 × Main effect 2). 0.2058 ≈ 1.8590 ÷ (3.1804 × 2.8398).